Paradoxical effect of cytotoxic chemotherapy on anemia in cancer patients with beta-thalassemia minor.
Del Mastro
L
L
Venturini
M
M
Costantini
M
M
Garrone
O
O
Sertoli
M R
MR
Bertelli
G
G
Machì
A M
AM
Rosso
R
R
D000740:Anemia / Q000209:etiology / Q000503:physiopathology*; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D003520:Cyclophosphamide / Q000008:administration & dosage; D004334:Drug Administration Schedule; D015251:Epirubicin / Q000008:administration & dosage; D004920:Erythropoiesis / Q000187:drug effects*; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D017086:beta-Thalassemia / Q000150:complications* / Q000503:physiopathology
D000903:Antibiotics, Antineoplastic; D000964:Antimetabolites, Antineoplastic; D018906:Antineoplastic Agents, Alkylating; D015251:Epirubicin; D003520:Cyclophosphamide; D005472:Fluorouracil